Skip to main content

Triamcinolone Hexacetonide Injection

Last Updated: October 11, 2022
Status: Current

Reason for the Shortage
    • Sandoz discontinued Aristospan in September 2020.
Available Products
    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Medexus in conjunction with FDA has initiated a temporary importation of Triamcinolone Hexacetonide (Hexatrione 2%) injectable suspension 20 mg/mL 2 mL ampules (NDC 59137-0570-01), to the U.S. market to address drug shortage. To place an order, please contact ANDA at1-855-336-3322, Option # 9. There is a side by side comparison between Aristospan and Hexatrione available at https://www.fda.gov/media/154709/download.

Updated

Updated October 11, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 22, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.